Loading clinical trials...
Loading clinical trials...
Clinical Protocol for Evaluation of the Jarvik 2000 Heart Assist System
The purpose of the study is to determine the safety and effectiveness of the Jarvik 2000 Heart as a bridge to heart transplantation in end-stage heart failure patients who are approved heart transplant candidates.
The Jarvik 2000 Heart is a silent compact axial flow impeller pump of 1 inch diameter, weighing 90g with a displacement volume of 25ml. The pump is implanted into the apex of the left ventricle by left thoracotomy, or by mid-sternotomy, or by the subcostal approach. A vascular graft offloads to either the descending thoracic aorta, the ascending thoracic aorta, or the abdominal aorta. The impeller rotates at speeds of 8,000 to 12,000 rpm providing blood flow of up to seven L/minute. At higher speeds the pump can produce 10 L/minute. Power is provided through an abdominal drive line.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
University of Maryland Medical Center
Baltimore, Maryland, United States
Start Date
April 1, 2005
Primary Completion Date
May 1, 2012
Completion Date
May 1, 2012
Last Updated
September 27, 2013
150
ACTUAL participants
The Jarvik 2000 Ventricular Assist System
DEVICE
Lead Sponsor
Jarvik Heart, Inc.
NCT07191730
NCT07484009
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions